Task shifting of intraocular injections from physicians to nurses: a randomized single-masked noninferiority study
- PMID: 31267688
- DOI: 10.1111/aos.14184
Task shifting of intraocular injections from physicians to nurses: a randomized single-masked noninferiority study
Abstract
Purpose: To test if task shifting of intraocular injections to nurses in a real-world setting can result in similar visual function outcome with equal safety profile.
Method: All patients with either age-related macular degeneration, retinal vein occlusion or diabetic macular oedema remitted to intraocular injections at a tertiary ophthalmology department in Norway between March 2015 and May 2017, were asked to participate. The participants were randomized to either nurse- or physician-administered intraocular injections of anti-vascular endothelial growth factor. The primary outcome measure was change in best-corrected visual acuity from baseline to 1-year follow-up. The mean difference in the primary outcome between the groups was analysed by a noninferiority test with a margin of three letters in disfavour of the nurse group. Adverse events were recorded.
Results: Three hundred and forty-two patients entered the study. Two hundred and fifty-nine completed the 1-year follow-up and were included in the study sample for the analysis of the primary outcome. Nurse-administered intraocular injections were noninferior to physician-administered injections with 0.7 and 1.6 letters gained, respectively (95% CI of the mean difference, -2.9 to 1.0; p = 0.019, one-sided t-test). Two thousand and seventy-seven injections and three ocular adverse events were recorded.
Conclusion: Task shifting of intraocular injections to nurses can be performed without increased risk to visual function. Such a task shift can alleviate the burden of performing intraocular injections in ophthalmology departments. To our knowledge, this is the first RCT on task shifting of a surgical procedure from physicians to nurses in a high-income country.
Keywords: age-related macular degeneration; intraocular injections; noninferior; nurse training; randomized controlled trial; task shifting.
© 2019 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.
References
-
- Austeng D, Morken TS, Bolme S, Follestad T & Halsteinli V (2016): Nurse-administered intravitreal injections of anti-VEGF: study protocol for noninferiority randomized controlled trial of safety, cost and patient satisfaction. BMC Ophthalmol 16: 169.
-
- Berg K, Pedersen TR, Sandvik L & Bragadottir R (2015): Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol. Ophthalmology 122: 146-152.
-
- Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP & Schneider S (2006): Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355: 1432-1444.
-
- Browning DJ (2018): Physician assistants and nurse practitioners in ophthalmology-has the time come? Am J Ophthalmol 186: ix-xi.
-
- Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Wordsworth S & Reeves BC (2012): Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology 119: 1399-1411.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical